Intratracheal Administration of siRNA Triggers mRNA Silencing in Lung to Modulate T Cell Immune Response and Lung Inflammation

Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2019.02.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Intratracheal Administration of Locked Nucleic Acid Containing Antisense Oligonucleotides Induced Gene Silencing and an Immune-Stimulatory Effect in the Murine Lung

PLoS ONE
Multidisciplinary
2017English

Proteoglycans: Key Regulators of Pulmonary Inflammation and the Innate Immune Response to Lung Infection

Anatomical Record
EvolutionEcologySystematicsAnatomyHistologyBehaviorBiotechnology
2010English

Intratracheal Administration of Influenza Virus Is Superior to Intranasal Administration as a Model of Acute Lung Injury

Journal of Virological Methods
Virology
2014English

Comparison of Rat Lung Tissue Following Inhalation and Intratracheal Administration of Metal Oxide Nanoparticles

Microscopy and Microanalysis
Instrumentation
2016English

In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response

PLoS ONE
Multidisciplinary
2015English

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer

Frontiers in Immunology
AllergyImmunology
2018English

siRNA Delivery to the Lung: What's New?

Advanced Drug Delivery Reviews
Pharmaceutical Science
2014English

Blood Immune Cell Biomarkers in Lung Cancer

Clinical and Experimental Immunology
AllergyImmunology
2018English

LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-Small Cell Lung Cancer Plasticity and Therapeutic Response

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy